9 results on '"Paduano, D."'
Search Results
2. Haemocer Plus in the treatment and prevention of lower GI post-resectional bleeding: prospective multicenter registry
- Author
-
Auriemma, F., additional, Andrisani, G., additional, Facciorusso, A., additional, Calabrese, F., additional, Citterio, N., additional, Paduano, D., additional, Gentile, C., additional, Spertino, M., additional, Marcozzi, G., additional, Hassan, C., additional, Di Matteo, F. M., additional, Repici, A., additional, and Mangiavillano, B., additional
- Published
- 2024
- Full Text
- View/download PDF
3. OC.17.6: OUTCOMES OF LUMEN APPOSING METAL STENT PLACEMENT IN PATIENTS WITH SURGICALLY ALTERED ANATOMY: A MULTICENTER INTERNATIONAL EXPERIENCE
- Author
-
Mangiavillano, B., primary, Ramai, D., additional, Gentile, C., additional, Samanta, J., additional, Bronswijk, M., additional, Van Der Merwe, S., additional, Kouanda, A., additional, Hyun, J., additional, Sun-Chuan, D., additional, Deprez, P., additional, Vargas-Madrigal, J., additional, Forti, E., additional, Mutignani, M., additional, Vanella, G., additional, Leone, R., additional, Arcidiacono, P.G., additional, Robles-Medranda, C., additional, Alcivar-Vasquez, J., additional, Arevalo-Mora, M., additional, Fugazza, A., additional, Ko, C., additional, Lisotti, A., additional, Larghi, A., additional, Rizzatti, G., additional, Galasso, D., additional, Di Matteo, F.M., additional, Stigliano, S., additional, Pham, K.D., additional, Fusaroli, P., additional, Di Mitri, R., additional, Amata, M., additional, Crinò, S.F., additional, Ofosu, A., additional, Binda, C., additional, Fabbri, C., additional, Morris, J.D., additional, Auriemma, F., additional, Paduano, D., additional, Calabrese, F., additional, Hassan, C., additional, Repici, A., additional, and Facciorusso, A., additional
- Published
- 2024
- Full Text
- View/download PDF
4. Outcomes Of Lumen Apposing Metal Stent Placement In Patients With Surgically Altered Anatomy: A Multicenter International Experience
- Author
-
Mangiavillano, B., additional, Ramai, D., additional, Gentile, C., additional, Samanta, J., additional, Dahr, J., additional, Bronswijk, M., additional, Van der Merwe, S., additional, Kouanda, A., additional, Hyun, J., additional, Sun-Chuan, D., additional, Deprez, P., additional, Jorge, V. M., additional, Forti, E., additional, Mutignani, M., additional, Vanella, G., additional, Leone, R., additional, Arcidiacono, P., additional, Robles-Medranda, C., additional, Alcivar-Vasquez, J., additional, Arevalo-Mora, M., additional, Fugazza, A., additional, Ko, C., additional, Lisotti, A., additional, Larghi, A., additional, Rizzatti, G., additional, Galasso, D., additional, Di Matteo, F. M., additional, Stigliano, S., additional, Pham, K.D. C., additional, Fusaroli, P., additional, Di Mitri, R., additional, Amata, M., additional, Crinò, S. F., additional, Ofosu, A., additional, Binda, C., additional, Fabbri, C., additional, Morris, J. D., additional, Auriemma, F., additional, Paduano, D., additional, Calabrese, F., additional, Hassan, C., additional, Repici, A., additional, and Facciorusso, A., additional
- Published
- 2024
- Full Text
- View/download PDF
5. Outcomes of lumen apposing metal stent placement in patients with surgically altered anatomy: Multicenter international experience.
- Author
-
Mangiavillano B, Ramai D, Kahaleh M, Tyberg A, Shahid H, Sarkar A, Samanta J, Dhar J, Bronswijk M, Van der Merwe S, Kouanda A, Ji H, Dai SC, Deprez P, Vargas-Madrigal J, Vanella G, Roberto L, Arcidiacono PG, Robles-Medranda C, Alcivar Vasquez J, Arevalo-Mora M, Fugazza A, Ko C, Morris J, Lisotti A, Fusaroli P, Dhaliwal A, Mutignani M, Forti E, Cottone I, Larghi A, Rizzatti G, Galasso D, Barbera C, Di Matteo FM, Stigliano S, Binda C, Fabbri C, Pham KD, Di Mitri R, Amata M, Crinó SF, Ofosu A, De Luca L, Al-Lehibi A, Auriemma F, Paduano D, Calabrese F, Gentile C, Hassan C, Repici A, and Facciorusso A
- Abstract
Background and study aims Although outcomes of lumen-apposing metal stents (LAMS) placement in native anatomy have been reported, data on LAMS placement in surgically altered anatomy (SAA) are sparse. We aimed to assess outcomes of LAMS placement in patients with SAA for different indications. Patients and methods This was an international, multicenter, retrospective, observational study at 25 tertiary care centers through November 2023. Consecutive patients with SAA who underwent LAMS placement were included. The primary outcome was technical success defined as correct placement of LAMS. Secondary outcomes were clinical success and safety. Results Two hundred and seventy patients (125 males; average age 61 ± 15 years) underwent LAMS placement with SAA. Procedures included EUS-directed transgastric ERCP (EDGE) and EUS-directed transenteric ERCP (EDEE) (n = 82), EUS-guided entero-enterostomy (n = 81), EUS-guided biliary drainage (n = 57), EUS-guided drainage of peri-pancreatic fluid collections (n = 48), and EUS-guided pancreaticogastrostomy (n = 2). Most cases utilized AXIOS stents (n = 255) compared with SPAXUS stents (n = 15). Overall, technical success was 98%, clinical success was 97%, and the adverse event (AE) rate was 12%. Using AGREE classification, five events were rated as Grade II, 21 events as Grade IIIa, and six events as IIIb. No difference in AEs were noted among stent types ( P = 0.52). Conclusions This study shows that placement of LAMS is associated with high technical and clinical success rates in patients with SAA. However, the rate of AEs is noteworthy, and thus, these procedures should be performed by expert endoscopists at tertiary centers., Competing Interests: Conflict of Interest Benedetto Mangiavillano has no conflict of interest regarding this paper but is consultant for Taewoong medical., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
- Published
- 2024
- Full Text
- View/download PDF
6. Establishing the optimal number of passes during EUS-FNB for diagnosis of pancreatic solid lesions: Prospective multicenter study.
- Author
-
Mangiavillano B, Facciorusso A, Di Matteo FM, Barbera C, Larghi A, Rizzatti G, Carrara S, Lisotti A, Fusaroli P, De Luca L, Di Leo M, Conti Bellocchi MC, Spadaccini M, Dabizzi E, Auriemma F, Stigliano S, Ramai D, Calabrese F, Manfrin E, Paduano D, Hassan C, Repici A, and Crinó SF
- Abstract
Background and study aims The optimal number of needle passes during endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is not yet established. We aimed to perform a per-pass analysis of the diagnostic accuracy of EUS-FNB of solid pancreatic lesions using a 22G Franseen needle. Patients and methods Consecutive patients with solid pancreatic lesions referred to 11 Italian centers were prospectively enrolled. Three needle passes were performed; specimens were collected after each pass and processed individually as standard histology following macroscopic on-site evaluation (MOSE) by the endoscopist. The primary endpoint was diagnostic accuracy of each sequential pass. Final diagnosis was established based on surgical pathology or a clinical course of at least 6 months. Secondary endpoints were specimen adequacy, MOSE reliability, factors impacting diagnostic accuracy, and procedure-related adverse events. Results A total of 504 samples from 168 patients were evaluated. Diagnostic accuracy was 90.5% (85.0%-94.1%) after one pass and 97.6% (94.1%-99.3%) after two passes ( P =0.01). Similarly, diagnostic sensitivity and sample adequacy were significantly higher adding the second needle pass (90.2%, 84.6%-94.3% vs 97.5%, 93.8%-99.3%, P =0.009 and 91.1%, 85.7%-94.9% vs 98.2%, 95.8%-99.3%, P =0.009, one pass vs two passes, respectively). Accuracy, sensitivity, and adequacy remained the same after the third pass. The concordance between MOSE and histological evaluation was 89.9%. The number of passes was the only factor associated with accuracy. One case of mild acute pancreatitis (0.6%) was managed conservatively. Conclusions At least two passes should be performed for the diagnosis of solid pancreatic lesions. MOSE is a reliable tool to predict the histological adequacy of specimens., Competing Interests: Conflict of Interest The authors declare that they have no conflict of interest., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
- Published
- 2024
- Full Text
- View/download PDF
7. Lumen-apposing metal stents for the treatment of pancreatic and peripancreatic fluid collections and bleeding risk: a propensity matched study.
- Author
-
Mangiavillano B, Lakhtakia S, Samanta J, Auriemma F, Vargas-Madrigal J, Arcidiacono PG, Barbera C, Ashhab H, Song TJ, Pham KD, Teoh AYB, Moon JH, Crinò SF, Kongkam P, Aragona G, De Lusong MA, Dhar J, Ofosu A, Ventra A, Paduano D, Franchellucci G, Repici A, Larghi A, and Facciorusso A
- Subjects
- Humans, Retrospective Studies, Stents adverse effects, Endosonography adverse effects, Drainage adverse effects, Hemorrhage etiology, Endoscopy, Gastrointestinal, Treatment Outcome, Pancreas, Pancreatic Diseases
- Abstract
Introduction: Endoscopic ultrasound (EUS)-guided drainage of symptomatic pancreatic fluid collections (PFCs) using the Hot-Axios device has recently been associated with a significant risk of bleeding. This adverse event (AE) seems to occur less frequently with the use of a different device, the Spaxus stent. The aim of the current study was to compare the rates of bleeding between the two stents., Methods: Patients admitted for treatment of PFCs by EUS plus lumen-apposing metal stent in 18 endoscopy referral centers between 10 July 2019 and 28 February 2022 were identified and their outcomes compared using a propensity-matching analysis., Results: 363 patients were evaluated. After a 1-to-1 propensity score match, 264 patients were selected (132 per group). The technical and clinical success rates were comparable between the two groups. Significantly more bleeding requiring transfusion and/or intervention occurred in the Hot-Axios group than in the Spaxus group (6.8% vs. 1.5%; P = 0.03); stent type was a significant predictor of bleeding in both univariate and multivariate regression analyses ( P = 0.03 and 0.04, respectively). Bleeding necessitating arterial embolization did not however differ significantly between the two groups (3.0% vs. 0%; P = 0.12). In addition, the Hot-Axios was associated with a significantly higher rate of overall AEs compared with the Spaxus stent (9.8% vs. 3.0%; P = 0.04)., Conclusion: Our study showed that, in patients with PFCs, bleeding requiring transfusion and/or intervention occurred significantly more frequently with use of the Hot-Axios stent than with the Spaxus stent, although this was not the case for bleeding requiring embolization., Competing Interests: Benedetto Mangiavillano received a fee for a speech from Taewoong; Khanh Do-Kong Pham is consultant for Taewoong, MITech and Cook medical; Stefano Francesco Crinò received a grant from Steris Endoscop Anthony Teoh is s a consultant for Boston Scientific, Cook, Taewoong, Microtech and MI Tech Medical Corporations. Mark Anthony De Lusong is consultant for Boston Scientific, Fujifilm and Olympus; Alessandro Repici is consultant for Boston Scientific, Fujifilm and Medtronic; Alberto Larghi is consultant for Boston Scientific, Pentax and MITech. The other Authors have no conflict of interest to declare., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Correction: Lumen-apposing metal stents for the treatment of pancreatic and peripancreatic fluid collections and bleeding risk: a propensity matched study.
- Author
-
Mangiavillano B, Lakhtakia S, Samanta J, Auriemma F, Vargas-Madrigal J, Arcidiacono PG, Barbera C, Ashhab H, Song TJ, Pham KD, Teoh AYB, Moon JH, Crinò SF, Kongkam P, Aragona G, De Lusong MA, Dhar J, Ofosu A, Ventra A, Paduano D, Franchellucci G, Repici A, Larghi A, and Facciorusso A
- Abstract
Competing Interests: Benedetto Mangiavillano received a fee for a speech from Taewoong; Khanh Do-Kong Pham is consultant for Taewoong, MITech and Cook medical; Stefano Francesco Crinò received a grant from Steris Endoscop Anthony Teoh is s a consultant for Boston Scientific, Cook, Taewoong, Microtech and MI Tech Medical Corporations. Mark Anthony De Lusong is consultant for Boston Scientific, Fujifilm and Olympus; Alessandro Repici is consultant for Boston Scientific, Fujifilm and Medtronic; Alberto Larghi is consultant for Boston Scientific, Pentax and MITech. The other Authors have no conflict of interest to declare
- Published
- 2024
- Full Text
- View/download PDF
9. Endoscopic ultrasound-guided gallbladder drainage as a first approach for jaundice palliation in unresectable malignant distal biliary obstruction: Prospective study.
- Author
-
Mangiavillano B, Moon JH, Facciorusso A, Vargas-Madrigal J, Di Matteo F, Rizzatti G, De Luca L, Forti E, Mutignani M, Al-Lehibi A, Paduano D, Bulajic M, Decembrino F, Auriemma F, Franchellucci G, De Marco A, Gentile C, Shin IS, Rea R, Massidda M, Calabrese F, Mirante VG, Ofosu A, Crinò SF, Hassan C, Repici A, and Larghi A
- Subjects
- Humans, Male, Middle Aged, Aged, Aged, 80 and over, Gallbladder, Prospective Studies, Endosonography methods, Drainage methods, Stents adverse effects, Cholangiopancreatography, Endoscopic Retrograde methods, Ultrasonography, Interventional methods, Cholestasis diagnostic imaging, Cholestasis etiology, Cholestasis surgery, Jaundice complications
- Abstract
Objectives: Endoscopic retrograde cholangiopancreatography (ERCP) represents the gold standard for jaundice palliation in patients with distal malignant biliary obstruction (DMBO). Biliary drainage using electrocautery lumen apposing metal stent (EC-LAMS) is currently a well-established procedure when ERCP fails. In a palliative setting the endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) could represent an easy and valid option. We performed a prospective study with a new EC-LAMS with the primary aim to assess the clinical success rate of EUS-GBD as a first-line approach to the palliation of DMBO., Methods: In all, 37 consecutive patients undergoing EUS-GBD with a new EC-LAMS were prospectively enrolled. Clinical success was defined as bilirubin level decrease >15% within 24 h and >50% within 14 days after EC-LAMS placement., Results: The mean age was 73.5 ± 10.8 years; there were 17 male patients (45.9%). EC-LAMS placement was technically feasible in all patients (100%) and the clinical success rate was 100%. Four patients (10.8%) experienced adverse events, one bleeding, one food impaction, and two cystic duct obstructions because of disease progression. No stent-related deaths were observed. The mean hospitalization was 7.7 ± 3.4 days. Median overall survival was 4 months (95% confidence interval 1-8)., Conclusion: Endoscopic ultrasound-guided gallbladder drainage with the new EC-LAMS is a valid option in palliative endoscopic biliary drainage as a first-step approach in low survival patients with malignant jaundice unfit for surgery. A smaller diameter EC-LAMS should be preferred, particularly if the drainage is performed through the stomach, to avoid potential food impaction, which could result in stent dysfunction., (© 2023 Japan Gastroenterological Endoscopy Society.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.